Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism

Diabetes

Volumn 46, Issue 11, 1997, Pages 1881-1887

  Pugliese, Giuseppe ^a   Pricci, Flavia ^a   Romeo, Giulio ^a   Pugliese, Francesco ^a,e   Mené, Paolo ^a   Giannini, Stefano ^b   Cresci, Barbara ^b   Galli, Gianna ^b   Rotella, Carlo M ^b   Vlassara, Helen ^c   Di Mario, Umberto ^d  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c PICOWER INST FOR MEDICAL RESEARCH   (United States)

^d UNIVERSITY MEDITERRANEA OF REGGIO CALABRIA   (Italy)

^e Diabet Endocrinol Metab Found   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE SERUM ALBUMIN; COLLAGEN TYPE 4; FIBRONECTIN; GLYCOSYLATED PROTEIN; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; LAMININ; MESSENGER RNA; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; DIABETES MELLITUS; DIABETIC NEPHROPATHY; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPERGLYCEMIA; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION;

EID: 15144357680     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.11.1881     Document Type: Article

References (45)

1. Cohen MP, Ziyadeh FN: Role of Amadori-modified nonenzymatically glycated serum proteins in the pathogenesis of diabetic nephropathy. J Am Soc Nephrol 7:183-190, 1996
2. Vlassara H, Bucala R, Striker LJ: Pathogenic effects of advanced glycosylation: biochemical, biological, and clinical implications for diabetes and aging. Lab Invest 70:138-151, 1994
3. Vlassara H: Protein glycation in the kidney: role in diabetes and aging. Kidney Int 49:1785-1804, 1996
4. Soulis-Liparota T, Cooper M, Papazoglou D, Clarke B, Jerums G: Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozotocin-induced diabetic rat. Diabetes 40:1328-1334, 1991
5. Vlassara H, Striker LJ, Teichberg S, Fuh H, Li YM, Steffes MW: Advanced glycation endproducts induce glomerular sclerosis and albuminuria in normal rats. Proc Natl Acad Sci U S A 91:11704-11708, 1994
6. Yang C-W, Vlassara H, Peten EP, He C-J, Striker GE, Striker LJ: Advanced glycation endproducts up-regulate gene expression found in diabetic giomerular disease. Proc Natl Acad Sci U S A 91:9436-9440, 1994
7. Edelstein D, Brownlee M: Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine. Diabetes 41:26-29, 1992
8. Vlassara H, Brownlee M, Cerami A: Novel macrophage receptor for glucose-modified proteins is distinct from previously described scavenger receptors. J Exp Med 164:1301-1309, 1986
9. Esposito C, Gerlach H, Brett J, Stern D, Vlassara H: Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J Exp Med 170:1387-1407, 1989
10. Skolnik E, Yang Z, Makita Z, Radoff S, Kirstein M, Vlassara H: Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy. J Exp Med 174:931-939, 1991
11. Doi T, Vlassara H, Kirstein M, Yamada Y, Striker GE, Striker LJ: Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor. Proc Natl Acad Sci U S A 89:2873-2877, 1992
12. Li YM, Mitsuhashi T, Wojciechowicz D, Shimizu N, Li J, Stitt A, He C, Banerjee D, Vlassara H: Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80 K-H membrane proteins. Proc Natl Acad Sci, U S A 93:11047-11052, 1996
13. Vlassara H, Li YM, Imani Y, Wojciechowicz D, Yang A, Liu F-Y, Cerami A: Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complex. Mol Med 1:634-646, 1995
14. Steffes MW, Osterby R, Chavers B, Mauer SM: Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 38:1077-1081, 1989
15. Vlassara H, Brownlee M, Manogue KR, Dinarello CA, Pasagian A: Catechin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. Science 240:1546-1548, 1988
16. Kirstein M, Brett J, Radoff S, Ogawa S, Vlassara H: Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor role in vascular disease of diabetes and aging. Proc Natl Acad Sci U S A 87:9010-9014, 1990
17. Kirstein M, Aston C, Hints R, Vlassara H: Receptor-specific induction of insulin-like growth factor I in human monocytes by advanced glycosylation end product-modified proteins. J Clin Invest 90:439-446, 1992
18. Bucala R, Tracey KJ, Cerami A Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilation in experimental diabetes. J Clin Invest 87:432-438,1991
19. Sensi M, Pricci F, Pugliese G, De Rossi MG, Cristina A, Morano S, Pozzessere G, Valle E, Andreani D, Di Mario U: Enhanced tissue levels of advanced glycation endproducts in experimental diabetes: possible role in late diabetic complications. Diab Res Clin Pract 28:9-17, 1995
20. Sensi M, Pricci F, De Rossi MG, Bruno MR, Morano S, Capuozzo E, Di Mario U: Formation and ways of detecting advanced glycation endproducts in isolated human glomerular basement membrane and human serum albumin non-enzymatically glycated in vitro. J Diabetes Complications 3:88-91, 1989
21. Makita Z, Vlassara H, Crami A, Bucala R: Immunochemical detection of advanced glycosylation endproducts in vivo. J Biol Chem 267:5133-5138, 1992
22. Pugliese G, Pricci F, Pugliese F, Menè P, Lenti L, Andreani D, Galli G, Casini A, Bianchi S, Rotella CM, Di Mario U: Mechanisms of glucose-enhanced extracellular matrix accumulation in rat glomerular mesangial cells. Diabetes 43:478-490, 1994
23. Pricci F, Pugliese G, Romano G, Romeo G, Locuratolo N, Menè P, Pugliese F, Galli G, Casini A, Rotella CM, Di Mario U: Insulin-like growth factor (IGF)-I and IGF-II stimulate extracellular matrix production in human mesangial cells: comparison with transforming growth factor-β (TGF-β). Endocrinology 137:879-885, 1996
24. Pugliese G, Pricci F, Locuratolo N, Romeo G, Romano G, Giannini S, Cresci B, Galli G, Rotella CM, Di Mario U: Increased activity of the insulin-like growth factor system in mesangial cells cultured in high glucose conditions: relation to glucose-enhanced extracellular matrix production. Diabetologia 39:774-784, 1996
25. Chomczynski P, Sacchi N: Single step method of RNA isolation by acid guanidine thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-158, 1987
26. Hernandez ER, Hurwitz A, Vera A, Pellicer A, Adashi EY, LeRoith D, Roberts CT Jr: Expression of the genes encoding the insulin-like growth factors and their receptors in the human ovary. J Clin Endocrinol Metab 74:419-425, 1992
27. Adamo ML, Ben-Hur H, Roberts CT Jr, LeRoith D: Regulation of start site usage in the leader exons of the rat insulin-like growth factor-I gene by development, fasting, and diabetes. Mol Endocrinol 5:1677-1686, 1991
28. Dull TJ, Gray A, Hayflick JS, Ullrich A; Insulin-like grovrth factor II precursor gene organization in relation to insulin gene family. Nature 310:777-781, 1984
29. Ullrich A, Gray A, Tam AW, Yang-Feng T, Tsubokawa M, Collins C, Henzel W, Le Bon T, Kathuria S, Chen E, Jacobs S, Francke U, Ramachandran J, Fujita-Yamaguchi F: Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J 5:2503-2512, 1986
30. Braun L, Head JE, Panzica M, Mikumo R, Bell GI, Fausto N: Transforming growth factor βmRNA increases during liver regeneration: a possible paracrine mechanism of growth regulation. Proc Natl Acad Sci U S A 85:1539-1543, 1988
31. Schwartzbauer JE, Tamkun JW, Lemischka IR, Hynes RD: Three different fibronectin mRNA arise by alternative splicing within the coding region. Cell 35:421-431, 1983
32. Barlow PD, Green MN, Kurkinen M, Hogan BLM: Sequencing of laminin B chain cDNAs reveals C-terminal regions of coiled-coil alpha-helix. EMBO J 3:2355-2362, 1989
33. Pihlajaniemi T, Tryggvason M, Myers JC, Kurkinen M, Lebo R, Cheung MC, Prockop DJ, Boyd CD: cDNA clones coding for the pro-β1(IV) chain of human type IV procollagen reveal an unusual homology of amino acid sequences in two halves of the carboxyl-terminal domain. J Biol Chem 260:7681-7687, 1985
34. Nath P, Laurent M, Horn E, Sobel ME, Zon G, Vogeli G: Isolation of an α1 type-IV collagen cDNA using a synthetic oligodeoxynucleotide. Gene 43:301-304, 1986
35. Cleveland DV, Lopata MA, McDonald RI, Cowan NJ, Rutter WJ, Kirshner MW: Number and evolutionary conservation of α and β-tubulin and cytoplasmic β- and γ-actin genes using specific cloned cDNA probes. Cell 20:95-105,1980
36. Pankewycz OG, Guan J-X, Bolton WK, Gomez A, Benedict JF: Renal TGF-β regulation in spontaneously diabetic NOD mice with correlations in mesangial cells. Kidney Int 46:748-758, 1994
37. Crowley ST, Brownlee M, Edelstein D, Satriano JA, Mori T, Singhal PC, Schlondorff DO: Effects of nonenzymatic glycosylation of mesangial matrix on proliferation of mesangial cells. Diabetes 40:540-547, 1991
38. Cohen MP, Sharma K, Jin Y, Hud E, Wu V-Y, Tomaszewski J, Ziyadeh FN: Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists: a novel treatment strategy. J Clin Invest 95:2338-2345, 1995
39. Salazar R, Brandt R, Krantz S: Expression of fructosyllysine on human monocytes and monocyte-like cell lines. Biochim Biophys Acta 1266:57-63, 1995
40. Krantz S, Salazar R, Brandt R, Kellerman J, Lottspeich F: Purification and partial amino acid sequencing of a fructosyllysine-specific binding protein from cell membranes of the monocyte-like cell line U937. Biochim Biophys Acta 1266:109-112, 1995
41. Mullarkey CJ, Edelstein D, Brownlee M: Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem Biophys Res Commun 173:932-939, 1990
42. Giardino I, Edelstein D, Brownlee M: Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity: a model for intracellular glycosylation in diabetes. J Clin Invest 94:110-117, 1994
43. Flyvbjerg A, Thorlacius-Ussing O, Naeraa R, Ingerslev J, Orskov H: Kidney tissue somatomedin C and initial renal growth in diabetic and uninephrectomized rats. Diabetologia 31:310-314 1988
44. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E., Border WA: Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Scii U S A 90:1814-1818, 1993
45. Ziyadeh FN, Sharma K, Ericksen M, Wolf G: Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-β1. J Clin Invest 93:536-542, 1994